Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2.
Biberfeld
G
G
Karolinska Institute and Swedish Institute for Infectious Disease Control, Stockholm, Sweden.
Thorstensson
R
R
Putkonen
P
P
D016915:AIDS Vaccines / Q000276:immunology*; D000818:Animals; D003429:Cross Reactions; D004195:Disease Models, Animal; D015658:HIV Infections / Q000517:prevention & control*; D015498:HIV-2 / Q000276:immunology*; D000882:Haplorhini; D006801:Humans; D008251:Macaca; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D015302:Simian Immunodeficiency Virus / Q000276:immunology*; D015164:Vaccines, Inactivated / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
D016915:AIDS Vaccines; C078788:ALVAC vaccine; D015164:Vaccines, Inactivated; D014765:Viral Vaccines